Introduction & Context
Logistical staff layoffs, not inspector cuts, stalled travel, bottlenecking audits.
Background & History
Pandemic backlogs left 15 percent of planned audits incomplete last year.
Key Stakeholders & Perspectives
Consumer groups protest; state labs say resources are thin; manufacturers want clear rules.
Analysis & Implications
Reduced oversight could spike recalls and erode trust, costing firms more later.
Looking Ahead
Congress reviews FDA funding in June; proposals may restore travel budgets or outsource audits.